| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Burnett Patrick is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sale+OE | 72,952 | $8.73 | $636,705.63 | -14.8% | +23.4% | +50.6% | |
| May 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 9,555 | $8.74 | $83,489.68 | -3.5% | +17.1% | +77.2% | |
| Mar 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 4,782 | $11.12 | $53,181.58 | -1.7% | -25.4% | +22.4% | |
| Jan 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,325 | $3.54 | $4,691.56 | -2.3% | +182.2% | +324.5% | |
| Aug 21, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,605 | $7.04 | $11,302.20 | -1.3% | -71.5% | +15.7% | |
| Mar 6, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 851 | $15.26 | $12,989.15 | -1.4% | -41.1% | -25.0% | |
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,751 | $15.83 | $27,713.12 | -2.2% | -52.5% | -25.6% | |
| Jan 3, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,475 | $15.01 | $22,136.06 | -3.4% | -24.5% | -73.5% | |
| Mar 7, 2022 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,011 | $16.85 | $17,032.12 | -1.2% | +24.5% | -17.1% |